Anticancer Peptides
5 articles in this topic.
All Articles
Anticancer Peptides
Peptides Targeting p53-MDM2: Reactivating p53 in Cancer
Peptide inhibitors of the p53-MDM2 interaction restore tumor suppression in wild-type p53 cancers. Here's how they work and where they stand clinically.
14 min read|Mar 25, 2026
Anticancer Peptides
Pro-Apoptotic Peptides: Triggering Cancer Cell Death
Pro-apoptotic peptides force cancer cells to self-destruct by targeting Bcl-2 survival proteins and disrupting mitochondria. Here is what the research shows.
12 min read|Mar 25, 2026
Anticancer Peptides
Stapled Peptides in Cancer: Alpha-Helix Drugs
Stapled peptides lock alpha-helical shapes to enter cells and disrupt p53-MDM2 interactions. ALRN-6924 reached Phase 1. Here's what the science shows.
13 min read|Mar 25, 2026
Anticancer Peptides
Amphipathic Peptides vs Cancer Cell Membranes
Cancer cells have negatively charged membranes that amphipathic peptides exploit to selectively kill tumors. Here is what 9 studies reveal about this mechanism.
13 min read|Mar 22, 2026